AGORACOM-JC « AGORACOM Small-cap Investor Relations Blog

Author Archive

Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media – TODAY 4:30 PM Eastern $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 7:27 AM on Thursday, December 17th, 2020

TORONTO , Dec. 9, 2020 – Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) (” Kontrol ” or ” Company “) is pleased to announce that it will be hosting a webinar presentation for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

“Following the filing of our patent applications we are excited to demonstrate how the BioCloud technology operates and share that with the public,” says Paul Ghezzi , CEO Kontrol. “We will be providing a demonstration of BioCloud and access to the inner workings of the technology.”

As previously announced on November 30, 2020 , Kontrol has filed the following four patent applications for its BioCloud technology and the Company is pleased to provide the patent references:

UNITED STATES : Application No. 17/105,793
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

UNITED STATES : Application No. 17/105,813
SYSTEM AND METHOD FOR OPTICAL DETECTION OF PATHOGENS

UNITED STATES : Application No. 17/105,804
COLLECTION CHAMBER FOR AN AIR SAMPLING SYSTEM

CANADA
SYSTEM AND METHOD FOR DETECTING AIRBORNE PATHOGENS

Title:	Kontrol to Host BioCloud Technology Presentation for Investors, Analysts and Media

Event Date:	Thursday, December 17, 2020 – 4:30 PM Eastern Time

Presentation Type:	Audio with Presenter Controlled Slides and Teleconference

Event Link:	Webcast URL: https://www.webcaster4.com/Webcast/Page/2402/39134

Participant Numbers:	Toll Free: 877-407-0782 International: 201-689-8567

About Kontrol BioCloud TM

BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality over time. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, offices, retirement homes, hospitals, mass transportation and others.

Additional information about Kontrol BioCloud can be found on its website at www.kontrolbiocloud.com

BioCloud is an air quality technology and not a medical device. The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus). Safe Space Technology is a Kontrol Trademark.

About Kontrol Energy

Kontrol Energy Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol Energy provides a combination of software, hardware, and service solutions to its customers to improve energy management, air quality and continuous emission monitoring.

Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com

Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.

However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.

Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest
Posted in All Recent Posts, Kontrol Energy Corp. | Comments Off on Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host BioCloud Event for Investors, Analysts and Media – TODAY 4:30 PM Eastern $SNE $MSFT $HON $GOOGL $QCOM

Datametrex AI $DM.ca $DTMXF Ramps up COVID-19 Testing for Film & Television Sectors $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:22 AM on Thursday, December 17th, 2020

As of this coming January 2021, the Company has received order for an additional 3 film & TV productions in Toronto and an additional 6 l film & TV productions in Vancouver.
The Company is currently providing services to 6 production companies in Toronto and 11 production companies in Vancouver, administering approximately 6,000 tests per week.
The Company expects this will increase significantly with the additional projects which is seeing in its project pipeline.

Toronto, Ontario–(December 17, 2020) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC: DTMXF) (the “Company” or “Datametrex”) wishes to provide an update on film and television industry testing and lab facilities projects which it is undertaking in Canada.

As of this coming January 2021, the Company has received order for an additional 3 film & TV productions in Toronto and an additional 6 l film & TV productions in Vancouver. The Company is currently providing services to 6 production companies in Toronto and 11 production companies in Vancouver, administering approximately 6,000 tests per week. The Company expects this will increase significantly with the additional projects which is seeing in its project pipeline.

Datametrex has ramped up testing lab facilities in Vancouver. The lab now has a capacity of processing up to 10,000 COVID-19 tests per week with the ability to expand this capacity even further (if required).

Vancouver is the third-largest production centre in North America, worth CDN $3.2 billion during 2018/19, according to Creative BC. British Columbia is home to several world-class Film and TV studios, including Bridge Studios, Mammoth Studios, Vancouver Film Studios, North Shore Studios, Ironwood Studios, Canadian Motion Picture Park, and The Crossing Studios. (Source: CreativeBC Film Commission)

Entire film and TV production in Canada represent $8.92 billion in production volume, and full-time equivalent jobs represent 179,000 workers. In March 2020, the industry stopped worldwide and in Vancouver which represents 37% of Canadian productions, and the surrounding areas had 46 productions filming which does not include the TV commercial market. Each of the shows would have a minimum of a 100-person film crew. (Source: CreativeBC Film Commission)

The next largest film and television market is Ontario which represents 34% of Canadian productions and in 2019, Toronto’s film and television industry directly employed more than 28,000 people representing $3.17 billion in production volume. (Source: CreativeBC Film Commission)

“With Vancouver and Toronto feature-length movies and episodic series productions filming quickly ramping up, we feel that this will only expand the COVID-19 screening business for the film and TV industries,” said Marshall Gunter CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:
Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain “forward-looking information” or constitute “forward-looking statements” within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management’s current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: 1drop Inc., 7-Eleven, Covid Testing, covid19, CSE, datametrex, investments, Lighthouse Pictures Inc., Lotte, tsx, tsx-v
Posted in Datametrex AI Limited | Comments Off on Datametrex AI $DM.ca $DTMXF Ramps up COVID-19 Testing for Film & Television Sectors $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

FansUnite Entertainment $FANS.ca $FUNFF Announces Upsizing of Previously Announced Brokered Private Placement Led by Gravitas Securities Inc. to $11 Million Due to Strong Investor Demand $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 10:00 PM on Wednesday, December 16th, 2020

Pursuant to the increase, the Company will offer for sale up to an aggregate of 17,600,000 special warrants of the Company at a price of $0.625 per Special Warrant for aggregate gross proceeds of approximately $11 million
“Due to overwhelming demand from a broad range of investors, we have decided to increase our private placement offering to $11M from our previously announced target of $5M,” said Scott Burton, CEO of FansUnite Entertainment. “The upsizing of our financing provides us with confidence that the investment community believes in our continued vision of becoming a leader in the global iGaming industry, while providing us the necessary capital to pursue strategic opportunities to enhance shareholder value.”

Vancouver, British Columbia–(December 16, 2020) – FansUnite Entertainment Inc. (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company“), a technology company providing leading online gaming solutions, is pleased to announce that, due to strong investor demand, it has entered into an amended agreement with Gravitas Securities Inc., as lead agent and sole bookrunner (the “Lead Agent“) on its own behalf and, on behalf of a syndicate of agents including, Haywood Securities Inc. and Mackie Research Capital Corporation (collectively with the Lead Agent, the “Agents“), to increase the size of the previously announced private placement of the Company.

Pursuant to the increase, the Company will offer for sale up to an aggregate of 17,600,000 special warrants of the Company (the “Special Warrants“) at a price of $0.625 per Special Warrant for aggregate gross proceeds of approximately $11 million (the “Offering“). The Company has also amended the option granted to the Agents, to provide for the sale of up to an additional 2,640,000 Special Warrants (the “Over-Allotment Option“), which Over-Allotment Option is exercisable in whole or in part at any time up to 30 days following the closing of the Offering. The initial closing date is expected to be on or about the week of January 11th, 2021 (the “Closing Date” or “Closing“) and the Offering may be completed in one or more closings at the discretion of the Lead Agent.

Each Special Warrant shall be exercisable, for no additional consideration at the option of the holder, into one unit of the Company (each, a “Unit“), with each Unit being comprised of one common share of the Company (a “Common Share“) and one half (1/2) of one non-transferable Common Share purchase warrant (each whole warrant, a “Warrant“). Each Warrant will entitle the holder thereof to acquire one Common Share (each, a “Warrant Share“) at an exercise price of $0.78 per Warrant Share for a period of 24 months after Closing (the “Expiry Date“).

“Due to overwhelming demand from a broad range of investors, we have decided to increase our private placement offering to $11M from our previously announced target of $5M,” said Scott Burton, CEO of FansUnite Entertainment. “The upsizing of our financing provides us with confidence that the investment community believes in our continued vision of becoming a leader in the global iGaming industry, while providing us the necessary capital to pursue strategic opportunities to enhance shareholder value.”

The net proceeds raised under the Offering will be used for working capital and general corporate purposes.

As soon as reasonably practicable after the Closing, the Company will prepare and file with each of the securities regulatory authorities in each of the provinces of British Columbia, Alberta, Manitoba and Ontario, (the “Jurisdictions“) and obtain a receipt for, a final short form prospectus (the “Final Prospectus“), qualifying the distribution of the securities issued pursuant to the Offering, in compliance with applicable securities law, within sixty (60) days from the Closing of the Offering.

In the event that the Company has not received a receipt for the Final Prospectus within sixty (60) days following the Closing, each unexercised Special Warrant will thereafter entitle the holder thereof to receive upon the exercise thereof, at no additional consideration, one-and-one-tenth (1.10) Unit (instead of one Unit) (the “Penalty Ratio“), provided that nothing shall require the Company to issue fractional Units or Common Shares and Warrant Shares underlying such Units, and any fractions resulting from the application of the Penalty Ratio shall be rounded down to the nearest whole number.

This press release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws.

About FansUnite Entertainment Inc.

FansUnite is a global sports and entertainment company, focusing on technology related to regulated and lawful online gaming and other related products. FansUnite has produced a one of a kind complete iGaming platform, with a sports and esports focus geared for the next generation of online bettors and casino players. The platform includes products for pre-match betting, in-play betting, daily fantasy, content and a certified RNG to produce casino style chance games. The platform operates multiple B2C brands and B2B software for the online gambling industry. FansUnite also looks to acquire technology platforms and assets with high growth potential in new or developing markets.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎future outlook and anticipated events such as: the Offering, the use of proceeds from the Offering, the filing and receipt for the Final Prospectus, the ‎Company’s unique portfolio of assets; and discussion of future plans, projections, objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be materially different from ‎those expressed or implied by such forward-looking statements or forward-looking information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, 2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to update or revise any forward-‎looking statements or forward-looking information, whether as a result of new information, future events or ‎otherwise, except as required by applicable securities laws.

Tags: Allied Esports Entertainment Inc, Bragg Gaming Group Inc, CSE, EA sports, eGambling, egaming, Enthusiast Gaming Holdings Inc, esports, Fandom Sports Media Corp
Posted in FansUnite Entertainment Inc. | Comments Off on FansUnite Entertainment $FANS.ca $FUNFF Announces Upsizing of Previously Announced Brokered Private Placement Led by Gravitas Securities Inc. to $11 Million Due to Strong Investor Demand $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

PlantX $VEGA.ca Announces Closing of $11.5 Million Non-Brokered Private Placement $BYND $TSN $CAG $FMCI $VERY $MEAT

Posted by AGORACOM-JC at 7:29 PM on Wednesday, December 16th, 2020

Announced the completion of its previously-announced non-brokered private placement of 20,909,091 units of the Company at a price of $0.55 per Unit for aggregate gross proceeds of $11,500,000
The Offering included the exercise of the Company’s over-allotment option that increased the size of the Offering by an additional 15% from an originally anticipated size of $10,000,000

VANCOUVER, BC , Dec. 16, 2020 – PlantX Life Inc. (the ” Company ” or ” PlantX “) (CSE: VEGA ) (Frankfurt: WNT1) is pleased to announce the completion of its previously-announced non-brokered private placement (the ” Offering “) of 20,909,091 units of the Company (each a ” Unit “) at a price of $0.55 per Unit for aggregate gross proceeds of $11,500,000 . The Offering included the exercise of the Company’s over-allotment option that increased the size of the Offering by an additional 15% from an originally anticipated size of $10,000,000 .

The Offering was co-led by Psagot Investment House Ltd. (” Psagot “), an Israeli investment firm and Israel’s largest pension fund manager, and PlantX founder, Mr. Sean Dollinger . Psagot purchased 2,725,000 Units for gross proceeds of $1,498,750 and Mr. Dollinger purchased 1,000,000 Units for gross proceeds of $550,000 in the Offering. The Company intends to use the net proceeds from the Offering for business operations, expansion of its business and for general working capital purposes.

“We are beyond pleased with our closing and the support of Psagot,” said Sean Dollinger , PlantX founder. “This is just another sign that the plant-based industry is gaining traction around the globe and it’s only the beginning.”

Each Unit consisted of one (1) common share (a ” Common Share “) of the Company and one (1) Common Share purchase warrant (a ” Warrant “). Each Warrant entitles the holder to acquire one (1) Common Share at an exercise price of $0.75 per share until December 16, 2022 (the ” Warrant Expiry Date “). In the event that the trading price of the Common Shares on the Canadian Securities Exchange (or such other Canadian stock exchange on which the Common Shares are listed for trading) equals or exceeds $2.00 per Common Share for any period of 10 consecutive trading days, then the Company may, at its option, within 10 business days following such 10-day period, accelerate the Warrant Expiry Date by issuing a press release (a ” Warrant Acceleration Press Release “), and, in such case, the Warrant Expiry Date will be deemed to be 5:00 p.m. ( Vancouver time) on the 30th day following the issuance of the Warrant Acceleration Press Release (the ” Warrant Acceleration Option “).

Although the Offering was non-brokered, the Company compensated certain dealers (each, a ” Finder ” and collectively, the ” Finders “) that introduced subscribers to the Company by way of: (i) cash finders’ fee to each Finder equal to 7% of the aggregate gross proceeds of the subscribers introduced to the Company by such Finder (each a “Finder’s Fee ” and collectively, the ” Finders’ Fees “); and (ii) the issuance of non-transferable Common Share purchase warrants to each Finder equal to 7% of the aggregate Units of the subscribers introduced to the Company by such Finder (each a ” Finder’s Warrant ” and collectively, the ” Finders’ Warrants “). Each Finder’s Warrant entitles the Finder to acquire one (1) Common Share at an exercise price of $0.75 per share until the Warrant Expiry Date unless otherwise accelerated pursuant to the Warrant Acceleration Option. The Company paid a total of $430,495.65 in Finders’ Fees and issued an aggregate of 774,757 Finders’ Warrants to the Finders in connection with the Offering.

The securities issued in connection with the Offering, including the Finders’ Warrants, are subject to a four-month hold period ending on April 17, 2021 in accordance with applicable Canadian securities laws.

Certain insiders of the Company participated in the Offering and purchased an aggregate of 190,910 Units. Participation of such insiders in the Offering constituted a “related party transaction” as defined under Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (” MI 61-101 “), but was exempt from the formal valuation and minority shareholder approval requirements of MI 61-101, as neither the fair market value of the securities issued to the insiders nor the consideration paid by the insiders exceeded 25% of the Company’s market capitalization. None of the Company’s directors expressed any contrary views or disagreements with respect to the foregoing. The Company did not file a material change report 21 days prior to the closing of the Offering as the details of the participation of the insider of the Company had not been confirmed at that time.

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing, and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of like-minded consumers, and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.

About Psagot Investment House Ltd.

Psagot is one of Israel’s largest investment houses. Psagot manages approximately 165 billion NIS on behalf of close to one million private investors, business clients and institutional clients. The investment house offers its clients a wide range of investment tracks and investment instruments adapted to meet investors’ various needs. Psagot Investment House is owned by Apax Partners

The Company website is http://investor.PlantX.com/ .

Forward Looking-Formation

This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes, without limitation, statements regarding the proposed use of the net proceeds from the Offering and the business and strategic plans of the Company.

By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.

Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Tags: Bloombox Club Limited, clean eats, CSE, Liv Marketplace LLC, Odacité, pet food, plant based pet foods, plant-based, Plantx
Posted in PlantX Life Inc. | Comments Off on PlantX $VEGA.ca Announces Closing of $11.5 Million Non-Brokered Private Placement $BYND $TSN $CAG $FMCI $VERY $MEAT

EVENT: Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host #BioCloud Event for Investors, Analysts and Media – Thursday, Dec. 17, 2020, at 4:30 p.m. EST $SNE $MSFT $HON $GOOGL $QCOM

Posted by AGORACOM-JC at 4:31 PM on Wednesday, December 16th, 2020

Kontrol Energy Corp. ( CSE: KNR ) ( OTCQB: KNRLF ) ( FSE: 1K8 ) will be hosting a webinar presentation for investors, analysts and media for its Covid-19 detection technology (“BioCloud analyzer” or “BioCloud”). The purpose of the presentation is to provide an operating demonstration and take questions from the audience.

Title: Kontrol to host BioCloud technology presentation for investors, analysts and media

Event date: Thursday, Dec. 17, 2020, at 4:30 p.m. Eastern Time

Presentation type: audio with presenter controlled slides and teleconference

Webcast event link: https://www.webcaster4.com/Webcast/Page/2402/39134

Participant numbers

Toll-free: 877-407-0782

International: 201-689-8567

Tags: BioCloud, COVID-19, CSA, CSA Standards, CSE, energy conservation, google nest, small cap
Posted in Kontrol Energy Corp. | Comments Off on EVENT: Kontrol $KNR $KNR.ca $KNR.c $KNRLF to host #BioCloud Event for Investors, Analysts and Media – Thursday, Dec. 17, 2020, at 4:30 p.m. EST $SNE $MSFT $HON $GOOGL $QCOM

Innocan Pharma $INNO.ca Announces the Successful Completion of Its First Full-Scale Manufacturing Run in Europe and the Commencement of Its Full-Scale Manufacturing Run in the USA $CGC.ca $APHA $OVAT.ca $KHRN.ca

Posted by AGORACOM-JC at 4:13 PM on Wednesday, December 16th, 2020

Announced the completion of its first commercial production of the Shir premium cosmetic line and Relief & Go topicals in Portugal and is pleased to announce the commencement of production in the United States, for the first time
Innocan has successfully completed its first commercial manufacturing run of in Europe/Portugal and will commence a first manufacturing run in North America.
In Portugal, InnoCan has now a storage of 35,000 Units of our SHIR™ and Relief & Go™ line and will commence a first manufacturing run in North America, effective immediately to manufacture an initial stock of 40.000 units.
These production activities will enable the Company to deliver product to the European and US markets accordingly.

Herzliya, Israel and Calgary, Alberta–(December 16, 2020) – Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC Pink: INNPF) (the “Company” or “Innocan”), is pleased to announce the completion of its first commercial production of the Shir premium cosmetic line and Relief & Go topicals in Portugal and is pleased to announce the commencement of production in the United States, for the first time.

Innocan has successfully completed its first commercial manufacturing run of in Europe/Portugal and will commence a first manufacturing run in North America. In Portugal, InnoCan has now a storage of 35,000 Units of our SHIR™ and Relief & Go™ line and will commence a first manufacturing run in North America, effective immediately to manufacture an initial stock of 40.000 units. These production activities will enable the Company to deliver product to the European and US markets accordingly.

Figure 1

To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6922/70446_4fe15a788442696d_002full.jpg

Innocan sees this manufacturing advance as a major milestone in the Company’s commercialization, while maintaining a consistent and high-quality product. Innocan’s next step will be to produce additional inventory to service the Company’s expansion into the U.S. market as it rapidly expands into retail distribution and scales its online sales.

“We are moved by the immense and positive market-response to our long awaited product launch and are pleased to have the ability to increase our inventory following the demand demonstrated by our SHIR and R&G product lines,” said Iris Bincovich, CEO and Co-Founder of Innocan Pharma.

About Innocan

The Company, through its wholly owned Israeli subsidiary, Innocan Pharma Ltd. (“Innocan Israel”), is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol (“CBD“). Innocan Israel and Ramot at Tel Aviv University are collaborating on a new, revolutionary exosome-based technology that targets both central nervous system (CNS) indications and the COVID-19 Coronavirus using CBD. CBD-loaded exosomes hold the potential to help in the recovery of infected lung cells. This product, which is expected to be administrated by inhalation, will be tested against a variety of lung infections.

Innocan Israel signed a worldwide exclusive license agreement with Yissum, the commercial arm of the Hebrew University of Jerusalem to develop a CBD drug delivery platform based on a unique-controlled release liposome to be administrated by injection. Innocan Israel plans, together with Professor Berenholtz, Head of the Laboratory of Membrane and Liposome Research of the Hebrew University, to test the liposome platform on several potential indications. Innocan Israel is also working on a dermal product that integrates CBD with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals, including, but not limited to, topical treatments for relief of psoriasis symptoms as well as the treatment of muscle pain and rheumatic pain. The founders and officers of Innocan have commercially successful track records in the pharmaceutical and technology sectors in Israel and globally.

For further information, please contact:

For Innocan Pharma Corporation:
Iris Bincovich, CEO
+972-54-3012842
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATION SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Caution regarding forward-looking information

Certain information set forth in this news release, including, without limitation, information regarding the markets, requisite regulatory approvals and the anticipated timing for market entry, is forward-looking information within the meaning of applicable securities laws. By its nature, forward-looking information is subject to numerous risks and uncertainties, some of which are beyond Innocan’s control. The forward-looking information contained in this news release is based on certain key expectations and assumptions made by Innocan, including expectations and assumptions concerning the anticipated benefits of the products, satisfaction of regulatory requirements in various jurisdictions and satisfactory completion of requisite production and distribution arrangements.

Forward-looking information is subject to various risks and uncertainties which could cause actual results and experience to differ materially from the anticipated results or expectations expressed in this news release. The key risks and uncertainties include but are not limited to: general global and local (national) economic, market and business conditions; governmental and regulatory requirements and actions by governmental authorities; and relationships with suppliers, manufacturers, customers, business partners and competitors. There are also risks that are inherent in the nature of product distribution, including import / export matters and the failure to obtain any required regulatory and other approvals (or to do so in a timely manner) and availability in each market of product inputs and finished products. The anticipated timeline for entry to markets may change for a number of reasons, including the inability to secure necessary regulatory requirements, or the need for additional time to conclude and/or satisfy the manufacturing and distribution arrangements. As a result of the foregoing, readers should not place undue reliance on the forward-looking information contained in this news release concerning the timing of launch of product distribution. A comprehensive discussion of other risks that impact Innocan can also be found in Innocan’s public reports and filings which are available under Innocan’s profile at www.sedar.com.

Readers are cautioned that undue reliance should not be placed on forward-looking information as actual results may vary materially from the forward-looking information. Innocan does not undertake to update, correct or revise any forward looking information as a result of any new information, future events or otherwise, except as may be required by applicable law.

Tags: CBD Derma Cosmetics, CBD stocks, CSE, Facial Serum, Innocan, Khiron Life Sciences Corp, Ovation Science Inc., Relief & Go Pain Relief Spray, SHIR
Posted in Innocan Pharma Corporation | Comments Off on Innocan Pharma $INNO.ca Announces the Successful Completion of Its First Full-Scale Manufacturing Run in Europe and the Commencement of Its Full-Scale Manufacturing Run in the USA $CGC.ca $APHA $OVAT.ca $KHRN.ca

AGORACOM Small Cap 60: $KABN.ca Addressable Market is 100% of People Online $MOS.ca $MOGO.ca $CTZ.ca

Posted by AGORACOM-JC at 12:09 PM on Wednesday, December 16th, 2020

David Lucatch CEO, President & Chair of KABN Systems NA Holding Corp. (KABN:CSE) says their addressable market is 100% of people online due to the fact that every single person online needs to manage their identity. The company empowers users by giving them the tools to manage their self-sovereign identity and data online.

Hub On AGORACOM / Corporate Profile

Tags: blockchain, BOON, canadian fintech, Covid 19, crypto, CSE, kabn cash, KABN KASH
Posted in AGORACOM Small Cap 60, All Recent Posts, Featured, KABN, KABN Systems NA Holdings Corp. | Comments Off on AGORACOM Small Cap 60: $KABN.ca Addressable Market is 100% of People Online $MOS.ca $MOGO.ca $CTZ.ca

Binovi Technologies $VISN.ca $BNVIF To Host Annual General Meeting and Investors Conference Call $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

Posted by AGORACOM-JC at 11:05 AM on Wednesday, December 16th, 2020

Hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors.
The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations.
Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.

TORONTO, ON / December 16, 2020 / Binovi Technologies Corp. (Binovi) (OTCQB:BNVIF)(TSX-V:VISN)(FRA:2EYA) is hosting a conference call, today, December 16, 2020 in order to conduct its Annual General Meeting, and for interested investors. The formal part of the AGM will take approximately ten minutes followed by an update to investors and shareholders on the Company’s operations. Binovi CEO, Adam Cegielski, will host the call and answer questions from participants.

Conference Call:

Date: Wednesday, December 16, 2020
Time: 11:15am PST, 2:15pm EST
Dial-in: Tollfree – 1 (866) 365 4406. Passcode: 6096110#

For additional information on the Company, please visit https://www.binovi.com/binovi-connect

@BinoviVISN – Twitter & Instagram

About Binovi Connect

Binovi is digitizing the delivery of healthcare by providing users access to all points of their individual performance from their phone, tablet or desktop computer. Designed for vision optimization and the enhancement of skills related to cognitive performance, Binovi provides measurable results in less time, and with less effort. As a SAAS based solution, the Binovi Connect App is supported by specialized expert knowledge, unique data insights and supporting hardware to deliver customized, one-on-one cognitive training and learning protocols ideal for K-12 Students, Vision Care Specialists, and Sports Performance testing and training. Binovi is currently used in over 20 countries.

On behalf of the Board of Directors

Terry Booth
Executive Chairman

Adam Cegielski
Founder | CEO

Investor Relations
Email: [email protected]
Toll-free: 1 (844) 866-6162
https://www.binovi.com/investor-reports

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com. The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Tags: Binovi Touch, CSE, Eli Wilson. Eye therapy, eye training, neuro-visual performance, tsx
Posted in Binovi Technologies Corp. | Comments Off on Binovi Technologies $VISN.ca $BNVIF To Host Annual General Meeting and Investors Conference Call $EYPT $KALA $PTON $WELL.ca $DOC.ca $DOCRF

FansUnite Entertainment $FANS.ca $FUNFF and GameCo to Create the First #Esports Sportsbook in the United States with Sky Ute Casino in Colorado $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

Posted by AGORACOM-JC at 11:01 AM on Wednesday, December 16th, 2020

FansUnite will gain first-mover advantage into the U.S. esports betting market through long term partnership with GameCo
Announced its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino
To establish the first dedicated esports sportsbook in the United States.
Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.

Vancouver, British Columbia–(December 16, 2020) – FansUnite Entertainment Inc (CSE: FANS) (OTCQB: FUNFF) (“FansUnite” or the “Company”), a technology company providing leading online gaming solutions, is pleased to announce its partner, GameCo LLC (“GameCo”), a Las Vegas based pioneer in Video Game Gambling™, has entered into a partnership with US Bookmaking and Sky Ute Casino to establish the first dedicated esports sportsbook in the United States. Wholly owned subsidiary Askott Entertainment will supply its iGaming platform, Chameleon, as part of a fully integrated esports betting solution.

Through GameCo’s partnership with Sky Ute Casino and US Bookmaking, FansUnite will be the first iGaming solutions provider to receive significant exposure in the U.S. esports betting market.

As previously announced on September 2nd, 2020, FansUnite entered into a partnership with GameCo to establish a fully integrated turnkey esports betting solution for online casinos and sportsbooks in the United States. Under the agreement with GameCo and Sky Ute Casino, Askott Entertainment’s Chameleon iGaming Platform will form the basis of GameCo’s esports betting offering alongside GRID’s data platform and 10Star’s odds feed and risk management services, resulting in an esports sportsbook with extensive and broad-ranging services that are geared towards the younger demographic of online gamblers.

“We are delighted to be part of the first-ever real money esports sportsbook in the U.S. as it represents a major milestone for FansUnite and the entire betting community globally,” said Scott Burton, CEO of FansUnite Entertainment. “Entering the U.S. market has always been part of our growth roadmap and partnering with GameCo in September represented a channel for us to introduce our leading B2B esports betting solution to a sizable and growing market. This latest customer win has exceeded our own expectations and validates our technology, strategy, and legitimacy of our organization. With our first casino customer now in hand, we are eager to continue our collaboration with GameCo, GRID, and 10 Star to establish a larger presence in the U.S. market.”

Blaine Graboyes, Co-Founder and CEO of GameCo added, “This marks a new era for GameCo as we will be the frontrunners in capturing revenue from an untouched segment in the U.S. online casino market. We require the most innovative technology that will provide a strong backbone for our betting systems and we are pleased that FansUnite is able to fulfill that need with the Chameleon iGaming solutions.”

About FansUnite Entertainment Inc.

About GameCo

GameCo LLC creates revolutionary gaming products and experiences that drive growth and deliver a new, different, and younger player for digital and retail casinos. The inventor of the world’s first skill-based Video Game Gambling Machine (VGM™), GameCo’s omnichannel land-based and online platform combines the fun and interactivity of video games with the thrill and anticipation of gambling. Through its iGameCo brand, GameCo develops unique video game gambling titles for digital casinos and provides the first turnkey, outsourced, full-service esports betting solution built specifically for the regulated US market. GameCo’s Video Game Gambling™ platform and patent-pending GamersEdge™ technology enables game developers and publishers to distribute and monetize video games into regulated gaming markets. GameCo offers single player and esports-style multiplayer games with a wide portfolio of sports, casual, and arcade titles that also feature brand licenses from major studios and celebrities such as Steve Aoki from DJ Kid Millionaire LTD., “SOULCALIBUR™II” with BANDAI NAMCO Amusement Inc., and Star Trek™ with CBS Consumer Products, Inc.

GameCo LLC is privately held and headquartered in Las Vegas and currently licensed to operate in more than twenty gaming jurisdictions, including Nevada. For the latest GameCo news, please visit https://gameco.com/product or follow the company on Twitter at twitter.com/GameCoLLC.

For further information, please contact:

Prit Singh Investor Relations at FansUnite
[email protected]
(905) 510-7636

Scott Burton Chief Executive Officer of FansUnite
[email protected]

Darius Eghdami President of FansUnite
[email protected]

NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

FORWARD-LOOKING STATEMENTS: Certain information contained herein may constitute “forward-‎‎looking information” under Canadian securities legislation. Generally, forward-looking information can be ‎‎identified by the use of forward-looking terminology such as “believes,” “belief,” “expects,” “intends,” ‎‎‎”anticipates,” “potential,” “should,” “may,” “will,” “plans,” “continue” or similar expressions to be uncertain ‎‎and forward-looking. Forward-looking statements may include, without limitation, statements relating to ‎‎future outlook and anticipated events such as: the extent and range of FansUnite’s iGaming platform; target demographics of FansUnite; growth of the U.S. ‎market; expansion of FansUnite into the U.S. market; the position of FansUnite and GameCo as ‎frontrunners in the US online casino market; FansUnite’s ability to fulfill technology needs with its ‎platform; GameCo’s ability to enable the distribution and monetization of video games into the licensed ‎gaming market and to attract new customers;‎ business development ‎plans of FansUnite and GameCo; the Company’s unique portfolio of assets; and discussion of future plans, projections, ‎objectives, estimates ‎and forecasts and the timing related thereto. Forward-looking statements are based ‎on the Company’s ‎estimates and are subject to known and unknown risks, uncertainties and other factors ‎that may cause the ‎actual results, level of activity, performance or achievements of FansUnite to be ‎materially different from ‎those expressed or implied by such forward-looking statements or forward-looking ‎information. Additional ‎information regarding the risks and uncertainties relating to the Company’s business ‎are contained under ‎the heading “Risk Factors” in the Company’s Non-Offering Prospectus dated March 27, ‎‎2020 filed on its ‎issuer profile on SEDAR at www.sedar.com and risks related to global pandemics, ‎including the novel ‎coronavirus (COVID-19) global health pandemic, and the spread of other viruses or ‎pathogens and influence ‎of macroeconomic developments. Accordingly, readers should not place undue ‎reliance on forward-looking ‎statements and forward-looking information. The forward-looking statements in ‎this news release are made ‎as of the date of this release. FansUnite disclaims and does not undertake to ‎update or revise any forward-‎looking statements or forward-looking information, whether as a result of new ‎information, future events or ‎otherwise, except as required by applicable securities laws.‎

Tags: Allied Esports Entertainment Inc, Bragg Gaming Group Inc, CSE, EA sports, eGambling, egaming, Enthusiast Gaming Holdings Inc, esports, Fandom Sports Media Corp, Fortnite
Posted in FansUnite Entertainment Inc., Featured | Comments Off on FansUnite Entertainment $FANS.ca $FUNFF and GameCo to Create the First #Esports Sportsbook in the United States with Sky Ute Casino in Colorado $SCR.ca $BRAG.ca $TNA.ca $FDM.ca $JJ.ca

PyroGenesis $PYR.ca Signs Additional $1.1MM Contract with US Tunneling Company $RTN $NOC $UTX $DDD.ca $HPQ.ca

Posted by AGORACOM-JC at 8:45 AM on Wednesday, December 16th, 2020

Further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM.
The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM.
The Company has received $1.3MM to date under these contracts.
The Client’s name will remain confidential for competitive reasons.

MONTREAL, Dec. 16, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX: PYR) (OTCQB: PYRNF) (FRA: 8PY), (the “Company”, the “Corporation” or “PyroGenesis”) a Company that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, is pleased to announce today that, further to its press releases dated April 1 st and 21 st , 2020, it has signed an additional contract (the “Contract”) with a US based tunneling client (the “Client”) for approx. $1.1MM. The total value of all contracts, including the one announced today, entered into with the Client is in excess of $3.6MM. The Company has received $1.3MM to date under these contracts. The Client’s name will remain confidential for competitive reasons.

Based on these contracts, PyroGenesis will be designing, manufacturing, testing and supplying the Client with a plasma torch tailored specifically for tunneling (the “TT1 Torch”). The TT1 Torch is expected to be delivered in the second half of 2021, at which time it will then be tested. The Client is committed to purchase exclusively from PyroGenesis, and the Company is committed to exclusively supply the Client with plasma torches and auxiliary equipment for tunneling applications.

PyroGenesis’ high-powered plasma torch will be used to replace traditional tunneling methods. An important benefit in using plasma-based tools versus traditional methods is its potential to drill through all geologies with greater flexibility in size diameter, while at the same time being more economical, efficient and environmentally friendly.

“This is the second announcement PyroGenesis has made in as many months which highlight advances in our plasma torch offerings,” said Mr. P Peter Pascali, CEO and Chair of PyroGenesis. “As you can see, not only are our torch offerings steadily moving forward, but are doing so in totally independent applications. This bodes well for the future and once again, underscores both the interest in, and versatility of, our torch offerings which at the same time are being recognized as effective environmental solutions.”

About PyroGenesis Canada Inc

PyroGenesis Canada Inc., a high-tech company, is a leader in the design, development, manufacture and commercialization of advanced plasma processes and products. The Company provides its engineering and manufacturing expertise and its turnkey process equipment packages to customers in the defense, metallurgical, mining, advanced materials (including 3D printing), and environmental industries. With a team of experienced engineers, scientists and technicians working out of its Montreal office and its 3,800 m 2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. The Company’s core competencies allow PyroGenesis to provide innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. PyroGenesis’ operations are ISO 9001:2015 and AS9100D certified. For more information, please visit www.pyrogenesis.com .

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com . Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the Toronto Stock Exchange, its Regulation Services Provider (as that term is defined in the policies of the Toronto Stock Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:
Rodayna Kafal, Vice President, IR/Comms. and Strategic BD
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Tags: 3D Systems Corporation, drosrite, Northrop Grumman Corporation, plasma, plasma torch, powders, PUREVAP, PyroGenesis, Raytheon Company, stocks, tsx
Posted in Featured, PyroGenesis Canada Inc. | Comments Off on PyroGenesis $PYR.ca Signs Additional $1.1MM Contract with US Tunneling Company $RTN $NOC $UTX $DDD.ca $HPQ.ca

Author Archive

Categories